Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 447
Liberation From Mechanical Ventilation Using Extubation Advisor Decision Support
Using Neurotechology to Help Children With Physical Disability Due to Cerebral Palsy
for
Hemiparetic Cerebral Palsy
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 12 - 17
Code: NCT07269353
Recruiting
High-intensity Walking Rehabilitation in Outpatient Subacute Spinal Cord Injury
for
Spinal Cord Injuries (SCI)
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT07553923
Recruiting
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Edmonton, Surrey, Seattle WA, Winnipeg,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
for
Neurodevelopmental Abnormality
Location: Edmonton, Portland OR, Salt Lake City UT, Loma Linda CA,